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Background: Showing a prevalence rate of 0.5-0.8%, urogenital malformations discovered in newborns is regarded
relatively common. The aim of this study is to examine the efficacy of ultrasound diagnostics in detecting
developmental disorders in the urogenital system.
Methods: We have processed the prenatal sonographic and postnatal clinical details of 175 urogenital abnormalities
in 140 newborns delivered with urogenital malformation according to EUROCAT recommendations over a 5-year
period between 2006 and 2010. The patients were divided into three groups; Group 1: prenatal sonography and
postnatal examinations yielded fully identical results. Group 2: postnatally detected urogenital changes were partially
discovered in prenatal investigations. Group 3: prenatal sonography failed to detect the urogenital malformation
identified in postnatal examinations. Urogenital changes representing part of certain multiple disorders associated with
chromosomal aberration were investigated separately.
Results: Prenatal sonographic diagnosis and postnatal results completely coincided in 45%, i.e. 63/140 of cases in
newborns delivered with urogenital developmental disorders. In 34/140 cases (24%), discovery was partial, while in
43/140 patients (31%), no urogenital malformation was detected prenatally. No associated malformations were
observed in 108 cases, in 57 of which (53%), the results of prenatal ultrasonography and postnatal examinations
showed complete coincidence. Prenatally, urogenital changes were found in 11 patients (10%), whereas no urogenital
disorders were diagnosed in 40 cases (37%) by investigations prior to birth. Urogenital disorders were found to
represent part of multiple malformations in a total of 28 cases as follows: prenatal diagnosis of urogenital malformation
and the findings of postnatal examinations completely coincided in three patients (11%), partial coincidence was found
in 22 newborns (79%) and in another three patients (11%), the disorder was not detected prenatally. In four newborns,
chromosomal aberration was associated with the urogenital disorder; 45,X karyotype was detected in two patients,
trisomy 9 and trisomy 18 were found in one case each.
Conclusion: In approximately half of the cases, postnatally diagnosed abnormalities coincided with the prenatally
discovered fetal urogenital developmental disorders. The results have confirmed that ultrasonography plays an
important role in diagnosing urogenital malformations but it fails to detect all of the urogenital developmental
abnormalities.
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The prevalence a fetal malformation is high. Levi pub-
lished in 2002 a summary study, including the RADIUS
study and the EUROFETUS study. A total of 36 studies
925,675 fetuses were examined and in 18,443 cases, fetal
malformations were detected. The incidence of malfor-
mations was between 0.3-3.2%, the average prevalence of
2.0%. The sensitivity of ultrasonography in the detection
of developmental disorders: 13.3 to 82.4% (average sensi-
tivity: 40.4%, respectively) [1]. The sensitivity of ultra-
sound is gradually increased. Crane in 1994 published a
summary of the results of the RADIUS study (1987–
1991), in total, 7575 fetuses were examined, 182 defects
were detected, the prevalence of malformations was 2.4%,
the sensitivity of ultrasound was 35.7% [2]. The subsequent
Grandjean in 1999, summarized the EUROFETUS study
(1990–1993), 170 800 cases during pregnancy examin-
ation, 3,685 revealed malformations, fetal malformation
prevalence of 2.2%, the sensitivity is 64.1%, respectively [3].
Urogenital developmental malformations discovered in
newborns are regarded relatively common due to a preva-
lence rate of 0.5-0.8% according to the literature [4-6].
Several authors have discussed urogenital disorders [7,8]
including those of the kidneys [9-13], and examined
hydronephrosis prenatally and postnatally [14-21].
The aim of the current study is to examine the efficacy
of sonographic diagnosis in newborns with urogenital
developmental malformations.
Methods
We have processed in a prospetive study the prenatal
sonographic and postnatal clinical details of 175 uro-
genital abnormalities in 140 newborns delivered with
urogenital malformation at the 1st Department of Ob-
stetrics and Gynaecology over a 5-year period between
2006 and 2010. Our Prenatal diagnostic center, Perinatal
center and Ultrasound Laboratory is a referral unit to
which pregnant women with suspected fetal abnormality
are referred to.Table 1 Birth data of newborns with urogenital malformation
Type of anomalies Maternal age (years
Cases Average SD Min
Hydronephrosis 59 29.03 5.08 17
Other obstructive 18 28.61 6.04 17
Renal dysplasia - multicystic 17 26.82 6.53 17
Renal dysplasia - polycystic 3 29.33 3.06 26
Renal agenesis 16 30.56 6.10 18
Other urinary anomalies 22 28.55 5.63 16
Male genital anomalies 26 29.56 4.33 18
Female genital anomalies 14 32.14 5.57 21
Total 175 29.21 5.50 16Urogenital changes representing part of certain mul-
tiple disorders associated with chromosomal aberration
were investigated separately. According to EUROCAT
guidelines (European Surveillance of Congenital Anomal-
ies) we included major malformations and excluded minor
anomalies [22]. The patients were divided into three
groups; Group 1: prenatal sonography and postanatal ex-
aminations yielded fully identical results. Group 2: postna-
tally detected urogenital changes were partially discovered
in prenatal investigations. Group 3: prenatal sonography
failed to detect the urogenital malformation identified in
postnatal examinations. Newborns with two or more
major anomalies were classified as multiple malformations.
Among urogenital malformations, we individually in-
vestigated cases in which only pyelectasis could be de-
tected with no further anatomical changes that would
cause urinary tract obstruction. In order to make com-
parisons with international data we individually checked
cases in which the narrowing or obstruction of the ure-
ters and urethra had been detected. We also examined
the detectability of multicystic and polycystic renal dys-
plasia, renal agenesis, other urinary tract disorders and
genital malformations.
Sonographic investigations were performed in the
Ultrasound Laboratory of the 1st Department of Obstet-
rics and Gynaecology using Philips® HD 11XE (Philips
Ultrasound) and GE Voluson® 730PRO (GE Medical Sys-
tem Kretztechnik GmbH & Co OHG) and Medison
SA9900 ultrasound device (Medison Co. LTD). The in-
vestigations were conducted according to recommenda-
tions of FMF, and according to the protocol elaborated
by the Hungarian Society of Obstetric and Gynaeco-
logical Ultrasonography.
Statistical procession included the investigation of sen-
sitivity, specificity, false negative ratio, false positive ra-
tio, positive predictive value and negative predictive
value in the individual cases. Calculating significance, we
used the Chi-square (χ2) test. A disorder was regarded
significant in case p < 0.05 was established.s (n = 175)
) Gestational weeks Birth weight (grams)
Max Average SD Average SD
40 35.64 3.75 2808.68 826.99
40 34.72 4.43 2610.91 1116.7
41 35.82 5.03 2426.67 934.84
32 36.00 3.46 2740.00 860.87
40 33.81 5.53 1916.36 1318.54
41 35.00 3.59 2186.36 785.64
38 34.56 3.85 1929.23 928.97
40 36.36 3.10 2735.56 787.61
41 35.19 4.14 2484.71 1020.89
Table 2 Accuracy of prenatal detection of neonatal urogenital anomalies (n = 140)
I. totally discovered II. partially discovered III. not detected
Cases n % n % n %
Isolated urogenital abnormalities 108 57 52.8% 11 10.2% 40 37.0%
Associated with chromosome abnormalities 4 3 75.0% 1 25.0% 0 0.0%
Part of multiple malformation 28 3 10.7% 22 78.6% 3 10.7%
Total 140 63 45.0% 34 24.3% 43 30.7%
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Declaration of Helsinki. The work has been approved by
the ethical committee of the Institutional Review Board of
1st Department of Obstetrics and Gynecology and sub-
jects gave informed consent to the work.
Results
In the five-year period of investigation, 19 602 newborns
were delivered in our department, a total of 140 new-
borns having congenital urogenital malformations
among them (0.7%). During that period in our depart-
ment were 521 terminations of pregnancy because a fetal
malformations, total of 49 fetuses have urogenital mal-
formations among them (9.4%). Also during that period
there were 55 spontaneous abortions, and 7 of them
have urogenital malformations (12.7%).
Altogether, the 140 newborns exhibited 175 malforma-
tions, corresponding to a prevalence rate of 0.7%. Table 1
contains the details of newborns delivered with urogeni-
tal malformations. At the time of delivery, the mothers’
mean age was 29.2±5.5 years. On average, deliveries took
place around about the ‘verge’ of maturity – at a gesta-
tional age of 35.2±4.1 weeks – and the mean of birth
weights at 2484.7± 1020.9 g was also lower.
On average, 4.04±3.49 ultrasound tests were per-
formed during pregnancy; 8±5.57 and 5±3.24 prenatal
tests were done in babies born with chromosome aberra-
tion and multiple malformation, respectively.
Prenatal ultrasonographic diagnosis and postnatal re-
sults completely coincided in 45%, i.e. 63/140 cases inTable 3 Accuracy of prenatal detection of neonatal urogenita
Type of anomalies I. totally discovered
Cases n %
Hydronephrosis 59 44 74.58%
Other obstructive 18 16 88.89%
Renal dysplasia - multicystic 17 14 82.35%
Renal dysplasia - polycystic 3 3 100.00%
Renal agenesis 16 7 43.75%
Other urinary anomalies 22 3 13.64%
Male genital anomalies 26 0 0.00%
Female genital anomalies 14 8 57.14%
Total 175 95 54.29%newborns delivered with urogenital developmental disor-
ders. In 34/140 cases (24.3%) discovery was partial, while
in 43/140 patients (30.7%), no urogenital malformation
was detected (Table 2).
Of the 140 newborns, 108 were diagnosed with a sin-
gle urogenital malformation, 4 cases were associated
with chromosome aberrations whereas other multiple
malformations were detected in 28 babies.
In the 108 newborns in which urogenital malformation
was not associated with disorders in any other organ,
the results of prenatal ultrasound tests and postnatal ex-
aminations completely coincided in 57 babies (52.8%).
Urogenital changes diagnosed prenatally showed partial
agreement with postnatal findings in 11 newborns (10.2%)
whereas prenatal investigation failed to reveal any disor-
ders in 40 patients (37%).
Among the 28 patients with multiple malformation,
complete agreement between prenatal and postnatal
diagnoses was found in three cases (10.7%) whereas par-
tial agreement was seen in 22 newborns (78.6%). However,
no urogenital malformation was discovered prenatally in
three cases (10.7%). Two systems were affected in 12 cases
of multiple malformations and in 16 cases, the number of
affected systems was ≥3. The associated malformations
were as follows: disorders of the extremities (11 cases),
cardiovascular malformations (9 cases), disorders of the
abdomen and abdominal wall (9 cases), craniospinal mal-
formations and those of the facial cranium (6 cases each),
other thoracic disorders (5 cases). In two patients, the
associated disorder was diagnosed as fetal hydrops.l anomalies (n = 175)
II. partially discovered III. not detected
n % n %
2 3.39% 13 22.03%
2 11.11% 0 0.00%
1 5.88% 2 11.76%
0 0.00% 0 0.00%
4 25.00% 5 31.25%
10 45.45% 9 40.91%
0 0.00% 26 100.00%
1 7.14% 5 35.71%
20 11.43% 60 34.29%
Table 4 Statistical characteristics of prenatal detection of neonatal urogenital abnormalities (N = 175)
Type of anomalies I. totally discovered II. + III. not discovered Sensitivity Specificity Positive
predictive
value
Negative
predictive
value
Cases n % n %
Hydronephrosis 59 44 74.58% 15 25.42% 74.58% 98.87% 17.05% 99.92%
Other obstructive 18 16 88.89% 2 11.11% 88.89% 99.91% 47.06% 99.99%
Renal dysplasia - multicystic 17 14 82.35% 3 17.65% 82.35% 99.86% 34.15% 99.98%
Renal dysplasia - polycystic 3 3 100.00% 0 0.00% 100.00% 99.87% 11.11% 100.00%
Renal agenesis 16 7 43.75% 9 56.25% 43.75% 99.97% 58.33% 99.95%
Other urinary anomalies 22 3 13.64% 19 86.36% 13.64% 99.97% 37.50% 99.90%
Male genital anomalies 26 0 0.00% 26 100.00% 0.00% 99.99% 0.00% 99.86%
Female genital anomalies 14 8 57.14% 6 42.86% 57.14% 99.99% 80.00% 99.97%
Total 175 95 54.29% 80 45.71% 54.29% 98.43% 24.30% 99.57%
Beke et al. BMC Pregnancy and Childbirth 2014, 14:82 Page 4 of 6
http://www.biomedcentral.com/1471-2393/14/82Trisomy 9 was diagnosed in one of the four newborns
delivered with chromosome aberration (47,XY + 9); the
newborn exhibited signs of aortic atresia, hare-lips and
cleft palate, hypoplastic nails and distal phalanges in the
digits as well as unilateral renal agenesis. Trisomy 18
(47,XY + 18) was also detected in one case. In addition
to typical facial dysmorphism, the newborn had atrio-
ventricular septal defect (AVSD), single umbilical artery
and horseshoe kidney. Turner syndrome (X-monosomy)
was diagnosed in two patients, one of them being a case
of Turner mosaic syndrome (45,X/46,XX). In the latter
patient, unilateral ovarian cysts were also discovered.
The other newborn, with the non-mosaic form (45,X),
exhibited unilateral multicystic renal dysplasia.
Among the 140 newborns with urogenital malforma-
tions, 122, 17 and 1 were delivered after single, twin and
triple pregnancies, respectively. Except for two cases,
only one newborn was affected by a urogenital disorder
in twin and triple pregnancies. Urogenital disorders were
found in both fetuses in two pregnancies. In one of the
twin deliveries, both newborn boys had hypospadiasis. In
the other case, fetus A had atrial septal defect and unilateralTable 5 Other urinary anomalies
Type of anomalies Cases (n)
Duplicate of urinary tract 12
Duplex kidney 4
Pyleon duplex 7
Ureter duplex 2
Bladder exstrophy 2
Horseshoe kidney 4
Persistence urachus 1
Cystoanalis/cystourethral fistula 1
Other urinary anomalies 2
Total 22pyelectasis, whereas fetus B had pyelectasis and double
kidneys on the same side of his body.
The different urogenital disorders were examined sep-
arately. Among the 140 newborns, 175 urogenital disor-
ders were detected. In 77 cases, widening of the urinary
passages was found and 59 of those cases were affected
by hydronephrosis alone. In 18 patients, some other, ob-
structive anatomical disorders lay in the background of
widening. Cystic kidneys were found in 20 cases, in
which multicystic and polycystic renal dysplasia were de-
tected in 17 and 3 cases, respectively. In the remaining
two cases, a solitary renal cyst was detected. In 16 pa-
tients hypoplasia was identified, or the kidney could not
be detected, i.e. the latter cases confirmed the absence of
a kidney (Table 3). Table 4 shows the sensitivity, specifi-
city and positive and negative predictive values in the
detection of different urogenital malformations.
Table 5 itemizes other urinary tract malformations (22
cases). Duplicate of urinary tract to different degrees
were diagnoses in 12 cases. Female genital malforma-
tions could be recognized in 57.14% of the fetuses. No
prenatal diagnosis of male genital malformations wasTable 6 Gestational age at wich diagnosis was first
established
Type of anomalies Average week SD
Hydronephrosis 28.04 6.84
Other obstructive 26.94 6.84
Renal dysplasia - multicystic 26.07 6.26
Renal dysplasia - polycystic 28.67 2.08
Renal agenesis 28.18 7.22
Other urinary anomalies 29.19 6.65
Male genital anomalies 28.00 7.87
Female genital anomalies 29.42 6.78
Total 29.19 6.65
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nosis was first established (Table 6).
Discussion
Based on our study, the prevalence of urogenital malfor-
mations was 0.73%. Our data is in close correlation with
that of Fadda et al. (0.84%) and exceeded that of Levi
et al. (0.51%) [4,5].
In more than half of the cases (52.8%) in which urogeni-
tal malformation was the only problem, the disorder could
be fully detected prenatally (Table 2). The efficacy of de-
tection was much lower (10.7%) in case the disorder was
part of a multiple malformation, the explanation being
that the disorders in other organ systems interfered with
the detectability of mild urogenital malformations.
Based on our investigations, the sensitivity of detecting
urogenital malformations prenatally was 54.29% (Table 4),
which was in agreement with studies involving larger
populations. Fadda et al. processed the data of a period
of 25 years and found that among the 42,256 pregnan-
cies in their sample, urogenital disorders were diagnosed
postnatally in 356 cases and 196 cases prenatally, corre-
sponding to a sensitivity rate of 55.06% [4]. In a previous
study, Levi et al. investigated 16,370 pregnancies and
found the sensitivity rate at 66.67%; they detected uro-
genital disorders in the fetus in 49 out of 84 cases [5].
VanDorsten, however, had different results in a previous
study based on a much smaller sample (2,031 pregnan-
cies), in which the sensitivity of the test was 90% (18 out
of 20 cases) [6].
Comparing the individual disorders, our results showed
partial agreement with the findings in the literature. Fadda
et al. could detect hydronephrosis in 65/72 cases (90.3%)
prenatally. In our own studies, we considered pyelectasy
exceeding 10 mm and the disorder was found in 44/59
cases (74.58%) [4]. In other obstructive urinary tract disor-
ders, the ratio was higher, 16/18 (88.9%). Based on Fadda’s
results, it was found to be 46/55 (83.7%) in the fetus. Our
team diagnosed renal dysplasia in 14/17 cases (82.35%)
prenatally, in contrast with Fadda et al. who detected the
disorder in 12/18 cases (66.7%). Polycystic renal dysplasia
occurred in three cases in our sample while Fadda et al.
reported four patients in their study; the disorders were
detected prenatally in both studies.
Based on the above, the detection of renal and other
urinary tract disorders could be regarded as successful
but genital disorders were found at a much lower rate.
Fadda et al. detected genital disorders in 43/102 fetuses
(42.2%), while the relevant data were 8/40 cases (20%) in
our sample. The detection of all ovarian malformations
was a major achievement in recognizing female genital
disorders prenatally, but no other female genital malfor-
mations or male genital disorders were identified in pre-
natal investigations.Conclusions
Postnatally and prenatally diagnosed fetal urogenital de-
velopmental malformations coincided in almost half of
the cases. Our results have confirmed that ultrasound
tests play an important role in diagnosing urogenital
malformations but they do not always allow the detec-
tion of all urogenital developmental malformations. It
has been concluded that among the disorders such as
fetal hydronephrosis and other obstructive uropathies as
well as the cases of renal dysplasia and female genital
malformations, it is ovarian cysts that can be detected
with great certainty in the fetus prenatally. In contrast,
other renal disorders and male genital malformations are
found at a low rate. Being aware of the above is import-
ant for experts performing ultrasound tests, health pro-
fessionals in providing genetic counselling and prenatal
care and, also, neonatologists and paediatricians seeing
newborns. During prenatal care, the expectant mother
should be given adequate information about the efficacy
of the examinations. If a malformation is detected post-
natally, the couple should also be informed how reliably
the specific malformation is detectable by prenatal
sonography.
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